FitLife Brands (FTLF) Stock Price, News & Analysis

Company Overview

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

Key Stats

• Today's Range: $18.11 to $18.90
• 50-Day Range: $12.43 to $19.13
• 52-Week Range: $9.83 to $19.19
• Volume: 9,394 shs
• Average Volume: 19,675 shs
• Market Capitalization: $170.78 million
• P/E Ratio: 21.65
• Dividend Yield: N/A
• Price Target: $23.00
• Consensus Rating: Moderate Buy

FitLife Brands Stock Analysis - MarketRank™

FitLife Brands scored higher than 84% of companies evaluated by MarketBeat, and ranked 167th out of 960 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

FitLife Brands has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

FitLife Brands has a consensus price target of $23.00, representing about 26.5% upside from its current price of $18.19.

Amount of Analyst Coverage

FitLife Brands has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 17.02%

Earnings Growth

Earnings for FitLife Brands are expected to grow by 17.02% in the coming year, from $0.94 to $1.10 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of FitLife Brands is 21.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.47.

Price to Earnings Ratio vs. Sector

The P/E ratio of FitLife Brands is 21.65, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.10.

Price to Book Value per Share Ratio

FitLife Brands has a P/B Ratio of 4.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.06% of the float of FitLife Brands has been sold short.

Short Interest Ratio / Days to Cover

FitLife Brands has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in FitLife Brands has recently decreased by 12.19%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

FitLife Brands does not currently pay a dividend.

Dividend Growth

FitLife Brands does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.06% of the float of FitLife Brands has been sold short.

Short Interest Ratio / Days to Cover

FitLife Brands has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in FitLife Brands has recently decreased by 12.19%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.79

News Sentiment

FitLife Brands has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.92 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for FitLife Brands this week, compared to 2 articles on an average week.

Search Interest

1 people have searched for FTLF on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added FitLife Brands to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, FitLife Brands insiders have not sold or bought any company stock.

Percentage Held by Insiders

61.40% of the stock of FitLife Brands is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 2.32% of the stock of FitLife Brands is held by institutions.

FTLF Stock Analysis - Frequently Asked Questions

How have FTLF shares performed this year?

FitLife Brands' stock was trading at $16.30 at the beginning of the year. Since then, FTLF shares have increased by 11.6% and is now trading at $18.1850.

How were FitLife Brands' earnings last quarter?

FitLife Brands Inc. (NASDAQ:FTLF) posted its quarterly earnings results on Thursday, August, 14th. The company reported $0.18 earnings per share for the quarter, hitting the consensus estimate of $0.18. The business had revenue of $16.13 million for the quarter, compared to analyst estimates of $16.17 million. FitLife Brands had a trailing twelve-month return on equity of 21.70% and a net margin of 12.63%.
Read the conference call transcript.

When did FitLife Brands' stock split?

FitLife Brands shares split on the morning of Friday, February 7th 2025.The 2-1 split was announced on Wednesday, February 5th 2025. The newly created shares were distributed to shareholders after the market closes on Thursday, February 6th 2025. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Who are FitLife Brands' major shareholders?

Top institutional shareholders of FitLife Brands include Geode Capital Management LLC (0.97%), New York State Common Retirement Fund (0.08%), Osaic Holdings Inc. (0.05%) and Bank of America Corp DE (0.02%). Insiders that own company stock include Matthew Lingenbrink and Patrick John Phillip Ryan.
View institutional ownership trends.

How do I buy shares of FitLife Brands?

Shares of FTLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of FitLife Brands own?

Based on aggregate information from My MarketBeat watchlists, some other companies that FitLife Brands investors own include NVIDIA (NVDA), Broadcom (AVGO), e.l.f. Beauty (ELF), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

• Last Earnings: 8/14/2025
• Today: 9/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:FTLF
• CIK: 1374328
• Web: www.fitlifebrands.com
• Phone: 402-991-5618
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Price Target and Rating

• Average Price Target for FitLife Brands: $23.00
• High Price Target: $25.00
• Low Price Target: $21.00
• Potential Upside/Downside: +26.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.84
• Trailing P/E Ratio: 21.68
• Forward P/E Ratio: 19.37
• P/E Growth: N/A
• Net Income: $8.98 million
• Net Margins: 12.63%
• Pretax Margin: 16.88%
• Return on Equity: 21.70%
• Return on Assets: 13.45%

Debt

• Debt-to-Equity Ratio: 0.15
• Current Ratio: 1.71
• Quick Ratio: 0.81

Sales & Book Value

• Annual Sales: $64.47 million
• Price / Sales: 2.65
• Cash Flow: $1.05 per share
• Price / Cash Flow: 17.41
• Book Value: $3.93 per share
• Price / Book: 4.63

Miscellaneous

• Outstanding Shares: 9,390,000
• Free Float: 3,625,000
• Market Cap: $170.99 million
• Optionable: Not Optionable
• Beta: 0.64